Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer

  • 1Email author,
  • 1,
  • 2,
  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 8,
  • 2 and
  • 2
EJNMMI Research20177:74

https://doi.org/10.1186/s13550-017-0323-y

Received: 25 August 2017

Accepted: 25 August 2017

Published: 8 September 2017

The original article was published in EJNMMI Research 2015 5:30

Erratum

Since publication of their article [1], the authors have become aware that there is an error in the description of the image data in the legend to Fig. 5. The second sentence of the legend should read as follows:

“The image data show radioactivity distribution in normal brain and cerebral metastases (enclosed in blue circle) (top panel) and are separated into blood (middle upper panel), non-blood (middle lower panel) and corresponding contrast-enhanced MRI images (bottom panel).”

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Imanova Centre for Imaging Sciences, Imperial College London, Hammersmith Hospital, Burlington Danes Building, London, UK
(2)
Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK
(3)
Division of Brain Sciences, Imperial College Department of Imaging, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
(4)
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK
(5)
Department of Molecular and Clinical Cancer Medicine, Duncan Building, Liverpool, UK
(6)
Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK
(7)
GlaxoSmithKline Oncology, Stockley Park West, Middlesex, UK
(8)
Clinical Imaging and Medicines Development, GlaxoSmithKline, Hertfordshire, UK

Reference

  1. Saleem A, Searle GE, Kenny LM, Huiban M, Kozlowski K, Waldman AD, Woodley L, Palmieri C, Lowdell C, Kaneko T, Murphy PS, Lau MR, Aboagye EO, Coombes RC. Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer. EJNMMI Res. 2015;5:30. doi:10.1186/s13550-015-0103-5.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement